VerityRank
Shanghai United Imaging Healthcare Co., Ltd.
Brand & Manufacturer VerifiedChina

Shanghai United Imaging Healthcare Co., Ltd.

United Imaging

United Imaging Healthcare is China's leading high-end medical imaging company, founded in 2011 and headquartered in Shanghai. The company was established with the explicit mission of breaking the global monopoly of the "GPS" trio (GE HealthCare, Philips, Siemens Healthineers) in advanced imaging, and has achieved full self-developed control over superconducting magnets, gradient coils, and high-end PET/CT systems. In FY2025, United Imaging generated CNY 13.80 billion in revenue, up 33.98% year-on-year, with net profit attributable to shareholders of CNY 1.87 billion, up 48.14%. The company employs 8,173 people, of whom a high proportion are R&D staff, with CNY 2.62 billion invested in R&D in 2025 (approximately 19% of revenue) — one of the highest R&D intensities in the medical device industry. United Imaging ships its products to more than 100 countries and regions, with overseas revenue reaching CNY 3.43 billion, up 51.39% year-on-year.

Strengths: United Imaging has built China's only complete high-end imaging portfolio spanning MRI, CT, PET/CT, PET/MR, X-ray, and radiation therapy (RT) systems. Its uEXPLORER total-body PET/CT, developed with UC Davis, achieved global recognition as the world's first total-body scanner. The company's R&D intensity of ~19% of revenue exceeds most Western peers, driving rapid product iteration across superconducting magnet and detector technologies. Overseas revenue growth above 51% demonstrates accelerating global acceptance of Chinese imaging technology, particularly in Europe, the Middle East, and Southeast Asia.
Weaknesses: United Imaging's overall revenue scale remains far below the global incumbents — CNY 13.8 billion versus GE HealthCare's USD 20.6 billion — limiting its R&D budget in absolute terms. The company faces domestic headwinds from China's anti-corruption campaign and VBP procurement reforms, which have pressured public hospital purchasing. As a relative newcomer, United Imaging's installed base and brand trust in mature Western markets remain limited, requiring sustained investment to displace entrenched competitors.
Read More
ChinaFounded 20118,173CNY$13.8 BManufacturing hubs in Shanghai… / 100
Listed onSSE688271
Last updated: 2026-11-21 17:10 ET·By VerityRank Research Team·Methodology

Listed market data

688271 · SSE · weeklyHistory →
Market cap
$14.4 B
Share price
CNY 117.04
1Y change
-18.2%
Recent change
-1.2%

11-19 → 11-20

Since first close
-35.4%

from 2022

Revenue (TTM)
CNY$13.8 B (FY2025)
· updated 2026-11-21 17:10 ETSource ↗

Financial history

Full market history
CNY 0$0CNY 38$5.0 BCNY 75$10.0 BCNY 113$15.0 BCNY 150$20.0 B2025-122026-012026-022026-032026-042026-052026-062026-072026-082026-092026-102026-11
MonthCloseMarket capChange
  • 2026-11CNY 117.04$14.4 B+1.8%
  • 2026-10CNY 115.00$14.2 B+7.1%
  • 2026-09CNY 107.37$13.3 B+2.7%
  • 2026-08CNY 104.50$12.9 B-9.5%
  • 2026-07CNY 115.52$14.3 B+14.1%
  • 2026-06CNY 101.23$12.5 B-15.9%
  • 2026-05CNY 120.30$14.8 B+9.4%
  • 2026-04CNY 109.95$13.6 B-1.8%
  • 2026-03CNY 112.00$13.8 B-14.3%
  • 2026-02CNY 130.70$16.1 B+1.1%
  • 2026-01CNY 129.30$16 B+3.0%
  • 2025-12CNY 125.50$15.5 B—
Monthly closes · 2025-12 – 2026-11 · Full market history

Ownership & Control

Latest available filings
Controlling entity
Publicly held — no controlling shareholder disclosed
Company type
Brand & Manufacturer
Insiders
56.59%
Institutions
9.75%(218 holders)
Free float
22.47%

Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.

In the press

All coverage →5 latest headlines2
Headlines aggregated from public feeds. Sentiment tags are keyword-based, not editorial judgement.

Company Overview

United Imaging Healthcare, founded in 2011 and headquartered in Shanghai, China, is the country's premier high-end medical imaging manufacturer and the fastest-rising challenger to the global imaging oligopoly. Listed on the Shanghai Stock Exchange STAR Market (688271), the company generated CNY 13.80 billion in revenue in FY2025 — up 33.98% year-on-year — with attributable net profit of CNY 1.87 billion, up 48.14%. Momentum continued into Q1 2026 with quarterly revenue of CNY 2.91 billion. United Imaging employs 8,173 people, including a research staff of extraordinary density, and invested CNY 2.62 billion in R&D during 2025, equivalent to roughly 19% of revenue — among the highest R&D intensities in the global medical device industry. The company serves more than 100 countries and regions, with overseas revenue growth of 51.39% year-on-year.

Core Strengths

United Imaging's competitive advantage rests on complete self-development of core components — a rare achievement in medical imaging. The company designs and manufactures its own superconducting magnets (up to 5.0T), gradient coils, RF chains, and PET detectors, technologies traditionally controlled by Western incumbents. This vertical integration underpins its flagship innovations: the uEXPLORER total-body PET/CT, developed in collaboration with UC Davis and recognized globally as the world's first total-body scanner capable of imaging the entire human body in a single scan; the uPMR 790 PET/MR; and the uRT-linac radiation therapy platform, making United Imaging one of the few companies worldwide offering both imaging and therapy in a unified portfolio. The company's uAI platform embeds artificial intelligence across acquisition, reconstruction, and diagnosis, differentiating its products in both clinical performance and workflow efficiency. Its R&D intensity of ~19% of revenue, combined with rapid product refresh cycles, has allowed the company to close the technology gap with the "GPS" incumbents within a single decade.

Global Presence

United Imaging's manufacturing and R&D footprint is anchored in China, with its headquarters campus in Shanghai and a second large manufacturing base in Wuhan. Internationally, the company has established five global R&D centers — including sites in Houston and Cleveland, United States — and a network of 14 manufacturing bases supporting regional demand. Its products are installed across more than 100 countries and regions, with particularly strong traction in Europe, the Middle East, Southeast Asia, and Latin America, where Chinese imaging systems offer competitive performance at accessible price points. The company has progressively built local service and training organizations in key markets to support installation, clinical collaboration, and remote diagnostics. Overseas revenue grew 51.39% in 2025, reflecting accelerating acceptance of United Imaging systems in academic medical centers and major hospital groups abroad.

Challenges & Outlook

United Imaging's growth trajectory faces two principal challenges. Domestically, China's healthcare anti-corruption campaign and centralized volume-based procurement (VBP) have pressured public hospital capital spending and compressed equipment pricing, requiring the company to accelerate its pivot toward international markets and high-value segments. Internationally, the company must overcome entrenched incumbents' installed bases, service networks, and brand trust in mature markets, while navigating evolving trade and technology-export restrictions between China, the United States, and Europe. Looking ahead, United Imaging is investing in next-generation photon-counting CT, ultra-high-field MRI, and AI-native diagnostics, while expanding its service-led recurring revenue model. With a fortress balance sheet, the highest R&D intensity in the industry, and a proven ability to displace incumbents in its home market, the company is positioned to become the first Chinese manufacturer to achieve genuine global scale in high-end medical imaging. VerityRank Score of 82/100

Quick Facts

Headquarters

Shanghai, China

Founded

2011

Employees

8,173

Revenue

CNY$13.8 B (FY2025)

Market cap

$14.4 B

Factories

Manufacturing hubs in Shanghai and Wuhan, China

Presence

Global: 100+ countries and regions
Categories

15 categories · scroll for more

Related

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website SSE STAR Market: 688271 , United Imaging News Center (Official)
United Imaging 2025 Annual Report & Q1 2026 Results (PR Newswire)
United Imaging Q3 2025 Results — Overseas Revenue Up 42% (PR Newswire)
Shanghai United Imaging Healthcare Investor Summary (Quartr)